Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selincro in Alcohol Dependence (SENSE)
NCT00811941Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Mar 2009
- Primary completion
- Nov 2010
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing Nalmefene Arm with Placebo Arm (2 arms). Primary endpoints: Number of Patients With Adverse Events at 52 weeks, Percentage of Patients Who Withdrew Due to Intolerance to Treatment at 52 weeks and 2 more. Started Mar 2009; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00811941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811941.